The Food and Drug Administration’s decision next week whether to approve the first treatment for Alzheimer’s disease highlights a deep…
Home »
First AI Device for Colonoscopy: Extra Set of Expert ‘Eyes’
The first artificial intelligence (AI) endoscopy module developed specifically to help detect adenomas during routine colonoscopy is making its debut…
Tweaked COVID Vaccines in Testing Aim to Fend Off Variants
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Dozens of Americans are rolling up…
OCS Heart System Earns Hard-Won Backing of FDA Panel
After more than 10 hours of intense debate, a US Food and Drug Administration (FDA) advisory panel gave its support…
FDA Approves Sarclisa (isatuximab-irfc) in Combination with Carfilzomib and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with…
FDA Clears Device to Protect Kids Against Head Injury
The US Food and Drug Administration (FDA) has cleared a new over-the-counter device designed to protect children aged 13 years…
FDA review reveals J&J COVID-19 vaccine safe, effective
A single-shot COVID-19 vaccine made by Johnson & Johnson completely prevented hospitalizations and deaths in a large clinical trial, according…
Pfizer asks the FDA to let it store its Covid vaccine at warmer temps
Pfizer asks the FDA to let it store its coronavirus vaccine at warmer temperatures after study showed its shot can…
FDA Approves Libtayo (cemiplimab-rwlc) as First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma
TARRYTOWN, N.Y. and PARIS, Feb. 9, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.…
FDA Approves Breyanzi
FDA Approves Breyanzi (lisocabtagene maraleucel) CAR-T Cell Therapy for Adults with Relapsed or Refractory Large B-cell Lymphoma PRINCETON, N.J.–(BUSINESS WIRE)…